131,591 Shares in Aveanna Healthcare Holdings Inc. $AVAH Bought by Precision Wealth Strategies LLC

Precision Wealth Strategies LLC bought a new position in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) during the fourth quarter, according to the company in its most recent filing with the SEC. The firm bought 131,591 shares of the company’s stock, valued at approximately $1,075,000. Precision Wealth Strategies LLC owned 0.06% of Aveanna Healthcare as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. AQR Capital Management LLC grew its holdings in Aveanna Healthcare by 21.2% in the 1st quarter. AQR Capital Management LLC now owns 26,280 shares of the company’s stock worth $142,000 after acquiring an additional 4,602 shares during the last quarter. Goldman Sachs Group Inc. grew its holdings in Aveanna Healthcare by 8.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 339,853 shares of the company’s stock worth $1,842,000 after acquiring an additional 25,974 shares during the last quarter. Jane Street Group LLC grew its holdings in Aveanna Healthcare by 522.0% in the 1st quarter. Jane Street Group LLC now owns 75,081 shares of the company’s stock worth $407,000 after acquiring an additional 63,010 shares during the last quarter. Creative Planning grew its holdings in Aveanna Healthcare by 15.1% in the 2nd quarter. Creative Planning now owns 47,025 shares of the company’s stock worth $246,000 after acquiring an additional 6,171 shares during the last quarter. Finally, JPMorgan Chase & Co. grew its holdings in Aveanna Healthcare by 65.0% in the 2nd quarter. JPMorgan Chase & Co. now owns 158,265 shares of the company’s stock worth $828,000 after acquiring an additional 62,348 shares during the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Aveanna Healthcare Stock Down 2.2%

NASDAQ AVAH traded down $0.14 during trading hours on Thursday, reaching $6.41. 68,959 shares of the company’s stock traded hands, compared to its average volume of 1,207,388. Aveanna Healthcare Holdings Inc. has a 52-week low of $3.73 and a 52-week high of $10.32. The firm has a market cap of $1.39 billion, a PE ratio of 6.26 and a beta of 2.08. The firm has a 50-day simple moving average of $6.80 and a 200 day simple moving average of $8.11. The company has a debt-to-equity ratio of 6.62, a current ratio of 1.32 and a quick ratio of 1.32.

Analyst Ratings Changes

AVAH has been the topic of a number of recent analyst reports. Truist Financial cut their price target on shares of Aveanna Healthcare from $9.00 to $8.00 and set a “hold” rating on the stock in a report on Monday, April 13th. BMO Capital Markets cut their target price on shares of Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating on the stock in a research note on Friday, March 20th. Zacks Research lowered shares of Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, February 3rd. Royal Bank Of Canada cut their target price on shares of Aveanna Healthcare from $11.00 to $9.00 and set a “sector perform” rating on the stock in a research note on Monday, March 23rd. Finally, Weiss Ratings lowered shares of Aveanna Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday, April 6th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat.com, Aveanna Healthcare currently has an average rating of “Moderate Buy” and an average price target of $10.25.

Insider Buying and Selling at Aveanna Healthcare

In related news, insider Patrick A. Cunningham sold 18,436 shares of Aveanna Healthcare stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $7.21, for a total transaction of $132,923.56. Following the completion of the transaction, the insider directly owned 337,755 shares of the company’s stock, valued at $2,435,213.55. This trade represents a 5.18% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Jeff Shaner sold 173,225 shares of Aveanna Healthcare stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $7.21, for a total transaction of $1,248,952.25. Following the completion of the transaction, the chief executive officer directly owned 2,650,892 shares of the company’s stock, valued at $19,112,931.32. This trade represents a 6.13% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 738,957 shares of company stock valued at $5,458,175. Insiders own 7.80% of the company’s stock.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.